about
Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyFructosamine measurement for diabetes mellitus diagnosis and monitoring: a systematic review and meta-analysis protocolMetabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in CameroonFasting insulin sensitivity indices are not better than routine clinical variables at predicting insulin sensitivity among Black Africans: a clamp study in sub-Saharan Africans.Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesHLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patientsStudy of the effect of altitude on the measurement of glycated haemoglobin using point-of-care instruments.Air pollution and risk of type 2 diabetes mellitus: a systematic review and meta-analysis.Genetic association studies of obesity in Africa: a systematic review.Genetic risk of type 2 diabetes in populations of the African continent: A systematic review and meta-analyses.Osteoprotegerin is not a determinant of metabolic syndrome in sub-Saharan Africans after age adjustment.Association of HLA class II markers with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a population of sub-Saharan African patients.Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.Stroke mortality and its determinants in a resource-limited setting: A prospective cohort study in Yaounde, Cameroon.Performance of three glomerular filtration rate estimation equations in a population of sub-Saharan Africans with Type 2 diabetes.Evaluation of a simple management protocol for hyperglycaemic crises using intramuscular insulin in a resource-limited setting.Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis.Metabolic profile of sub-Saharan African patients presenting with first-ever-in-lifetime stroke: association with insulin resistance.Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Cardiovascular risk profile, diabetes specific factors, and prevalent microvascular eye complications in sub-Saharan Africans with type 2 diabetesCorrection: Metabolic Syndrome and Fatal Outcomes in the Post-Stroke Event: A 5-Year Cohort Study in CameroonScreening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patientsCombined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D
P50
Q24239834-E9F88E09-D3FF-4A7B-BD23-77701E39EE0CQ26830015-D6041012-0026-41C8-8719-C3C4BEECC8D1Q28485919-0D4B112A-F7F4-4279-A418-88497689F850Q34033120-2AD7850F-4DEA-4BDC-AE84-05100FDD4CE9Q35207904-47C81A23-039C-45C0-A470-9ED41C7CD0AFQ36720640-778562B2-E1B6-4A74-BD79-8A731A0AE6A0Q36747880-9650BF1F-87A5-45B0-8340-7D26C6725317Q38254883-AF7D39A4-378B-42CD-B985-C0D25C936687Q38340326-8B90B099-F979-4798-BA54-E6D927EC5173Q38717885-37A7CE59-6AC6-4657-A8BB-3AE5FE752CD0Q38885310-A537DF02-ECF6-4E87-98FC-968335E10D84Q38890520-BF3B0761-E70A-416C-A03F-729DB03BCDE4Q39096821-A70A62B9-8655-4372-B26B-1F13B6A106DBQ40138764-7600612A-31D8-45B2-B5F3-1CCDB1FE8478Q41202492-3ABE8DA3-B6EE-4313-8DA8-1218620C3E2FQ41994014-643904F5-540E-40CA-9783-1CB88423CDD0Q42939250-540ED99D-7E4B-4F9A-A93E-6923CBAC7BC1Q46873743-6A954D65-D458-4F30-BE7E-2B38AF4F3AC7Q49110588-4E3506D3-B763-4F82-89AE-AC260BCB9B27Q61192620-19EC9F8F-53AF-47A4-9910-C50FCA6C497FQ61192625-685D9A0B-3C96-4B55-B943-7733E7C0FEBDQ61192630-A2207B8E-8245-402E-A909-9EE62C0CD3F4Q91375214-272A4973-53FA-4AE3-9C4A-82EB9C845848
P50
description
researcher ORCID ID = 0000-0003-4445-308X
@en
wetenschapper
@nl
name
Eric V Balti
@ast
Eric V Balti
@en
Eric V Balti
@es
Eric V Balti
@nl
type
label
Eric V Balti
@ast
Eric V Balti
@en
Eric V Balti
@es
Eric V Balti
@nl
prefLabel
Eric V Balti
@ast
Eric V Balti
@en
Eric V Balti
@es
Eric V Balti
@nl
P106
P1153
35483005800
P21
P31
P496
0000-0003-4445-308X